Annual Total Liabilities
$9.50 M
-$596.30 K-5.91%
30 September 2022
Summary:
NeuBase Therapeutics annual total liabilities is currently $9.50 million, with the most recent change of -$596.30 thousand (-5.91%) on 30 September 2022. During the last 3 years, it has fallen by -$596.30 thousand (-5.91%).NBSE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$9.48 M
-$1.60 M-14.46%
30 September 2023
Summary:
NeuBase Therapeutics quarterly total liabilities is currently $9.48 million, with the most recent change of -$1.60 million (-14.46%) on 30 September 2023.NBSE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -5.9% | -6.1% |
| 5 y5 years | +279.8% | +279.1% |
NBSE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -5.9% | -14.5% |
NeuBase Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $9.48 M(-14.5%) |
| June 2023 | - | $11.09 M(+58.1%) |
| Mar 2023 | - | $7.01 M(-4.7%) |
| Dec 2022 | - | $7.36 M(-22.5%) |
| Sept 2022 | $9.50 M(-5.9%) | $9.50 M(-1.9%) |
| June 2022 | - | $9.68 M(-9.0%) |
| Mar 2022 | - | $10.64 M(+7.4%) |
| Dec 2021 | - | $9.91 M(-1.9%) |
| Sept 2021 | $10.10 M(+220.6%) | $10.10 M(+11.7%) |
| June 2021 | - | $9.04 M(+155.8%) |
| Mar 2021 | - | $3.54 M(+57.7%) |
| Dec 2020 | - | $2.24 M(-28.8%) |
| Sept 2020 | $3.15 M(+25.9%) | $3.15 M(-9.3%) |
| June 2020 | - | $3.47 M(-6.9%) |
| Mar 2020 | - | $3.73 M(+30.8%) |
| Dec 2019 | - | $2.85 M(+13.9%) |
| Sept 2019 | $2.50 M(+758.3%) | $2.50 M(+232.8%) |
| June 2019 | - | $751.70 K(+20.3%) |
| Mar 2019 | - | $624.70 K(+4.6%) |
| Dec 2018 | - | $597.20 K(+104.9%) |
| Sept 2018 | $291.50 K(-94.3%) | $291.50 K(-67.2%) |
| June 2018 | - | $888.40 K(-48.7%) |
| Mar 2018 | - | $1.73 M(-53.8%) |
| Dec 2017 | - | $3.75 M(-26.3%) |
| Sept 2017 | $5.08 M(+13.4%) | $5.08 M(-11.5%) |
| June 2017 | - | $5.74 M(-18.4%) |
| Mar 2017 | - | $7.04 M(+81.2%) |
| Dec 2016 | - | $3.89 M(-13.3%) |
| Sept 2016 | $4.48 M(+15.5%) | $4.48 M(-15.3%) |
| June 2016 | - | $5.29 M(+50.6%) |
| Mar 2016 | - | $3.52 M(-33.4%) |
| Dec 2015 | - | $5.28 M(+36.0%) |
| Sept 2015 | $3.88 M(-26.4%) | $3.88 M(+3.4%) |
| June 2015 | - | $3.75 M(+14.2%) |
| Mar 2015 | - | $3.28 M(-51.5%) |
| Dec 2014 | - | $6.78 M(+28.5%) |
| Sept 2014 | $5.27 M(+999.2%) | $5.27 M(-22.1%) |
| June 2014 | - | $6.77 M(+639.6%) |
| Mar 2014 | - | $914.90 K(+265.7%) |
| Dec 2013 | - | $250.20 K(-47.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | $479.70 K(-56.0%) | $479.70 K(+88.8%) |
| June 2013 | - | $254.10 K(-20.1%) |
| Mar 2013 | - | $317.90 K(-86.7%) |
| Dec 2012 | - | $2.38 M(+118.5%) |
| Sept 2012 | $1.09 M(-82.4%) | $1.09 M(-54.9%) |
| June 2012 | - | $2.42 M(-7.6%) |
| Mar 2012 | - | $2.62 M(-52.6%) |
| Dec 2011 | - | $5.53 M(-10.8%) |
| Sept 2011 | $6.19 M(+245.2%) | $6.19 M(+19.4%) |
| June 2011 | - | $5.19 M(+120.1%) |
| Mar 2011 | - | $2.36 M(+0.8%) |
| Dec 2010 | - | $2.34 M(+30.3%) |
| Sept 2010 | $1.79 M(+190.4%) | $1.79 M(-39.2%) |
| June 2010 | - | $2.95 M(-6.1%) |
| Mar 2010 | - | $3.14 M(+633.3%) |
| Dec 2009 | - | $428.40 K(-30.7%) |
| Sept 2009 | $617.90 K(+318.6%) | $617.90 K(+1.6%) |
| June 2009 | - | $608.00 K(-21.5%) |
| Mar 2009 | - | $775.00 K(+442.0%) |
| Dec 2008 | - | $143.00 K(-3.1%) |
| Sept 2008 | $147.60 K(-84.7%) | $147.60 K(-25.8%) |
| June 2008 | - | $199.00 K(-39.0%) |
| Mar 2008 | - | $326.00 K(-47.4%) |
| Dec 2007 | - | $620.00 K(-35.8%) |
| Sept 2007 | $965.00 K(+143.9%) | $965.00 K(-10.0%) |
| June 2007 | - | $1.07 M(-47.9%) |
| Mar 2007 | - | $2.06 M(+420.0%) |
| Dec 2006 | $395.60 K(-28.7%) | $395.60 K(+2.3%) |
| Sept 2006 | - | $386.60 K(+5269.4%) |
| June 2006 | - | $7200.00(-98.8%) |
| Mar 2006 | - | $594.40 K(+7.1%) |
| Dec 2005 | $554.80 K(-10.2%) | $554.80 K(-24.4%) |
| Sept 2005 | - | $734.00 K(-4.0%) |
| June 2005 | - | $764.90 K(+4.5%) |
| Mar 2005 | - | $732.00 K(+18.4%) |
| Dec 2004 | $618.10 K(+64.6%) | $618.10 K(+12.5%) |
| Sept 2004 | - | $549.20 K(+18.4%) |
| June 2004 | - | $463.80 K(+3.1%) |
| Mar 2004 | - | $449.80 K |
| Dec 2003 | $375.50 K | - |
FAQ
- What is NeuBase Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for NeuBase Therapeutics?
What is NeuBase Therapeutics annual total liabilities?
The current annual total liabilities of NBSE is $9.50 M
What is the all time high annual total liabilities for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual total liabilities is $10.10 M
What is NeuBase Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NBSE is $9.48 M
What is the all time high quarterly total liabilities for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly total liabilities is $11.09 M